As changes in oligodendrocyte number have not been investigated in SCA2 to our knowledge, this represents an exciting advance connecting ATXN2 as a risk gene and oligodendrocyte dysregulation in ALS, although more direct evidence is required. This evidence concerns the gene ATXN2 and amyotrophic lateral sclerosis.